277
Views
6
CrossRef citations to date
0
Altmetric
Original Scientific Contributions

A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it’s not meningitisFootnote*

, , &
Pages 421-422 | Received 20 Aug 2018, Accepted 07 Oct 2018, Published online: 15 Nov 2018

References

  • Yetter O. Identification of the synthetic cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H indazole-3-carboxamide (CUMYL-4CN-BINACA) in plant material and quantification in post-mortem blood samples. J Analyt Toxiocl. 2017;41:720–728.
  • Åstrand A, Vikingsson S, Lindstedt D, et al. Metabolism study for CUMYL-4CN-BINACA in human hepatocytes and authentic urine specimens: free cyanide is formed during the main metabolic pathway. Drug Test Anal. 2018;10:1270–1279. doi: 10.1002/dta.2373
  • Horth RZ, Crouch B, Horowitz BZ, et al. Notes from the field: acute poisonings from a synthetic cannabinoid sold as cannabidiol – Utah, 2017–2018. Morb Mortal Wkly Rep. 2018;67:587–588.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.